Zusammenfassung
Weltweit wird ein Zuwachs an diagnostischen und therapeutisch-angiologischen oder kardiologischen Katheteruntersuchungen unter Verwendung von Röntgenkontrastmitteln beobachtet, die erwartungsgemäß von einer Zunahme an Fällen von Röntgenkontrastmittel-induzierter Nephropathie begleitet wird. In diesem Artikel wird eine Übersicht über Pathogenese, Klinik und prophylaktischen Maßnahmen zur Prävention der Röntgenkontrastmittel-induzierten Nephropathie gegeben. Die wichtigsten prophylaktischen Maßnahmen bestehen in der Identifizierung von Risikopatienten, in einer strengen Indikationsstellung für den Einsatz von Kontrastmitteluntersuchungen und Prüfung alternativer diagnostischer Verfahren wie z. B. Angio-MRT, die Verwendung nicht-ionischer, niedrig-osmolarer oder - neuerdings - iso-osmolarer Kontrastmittel, und eine großzügige Hydrierung mit 0,9 %iger NaCl-Lösung vor/während der Intervention mit additiver Gabe von Acetylcystein.
Summary
The use of diagnostic and therapeutic catheterization is increasing and so is the exposure to radiocontrast media. As a consequence, an increasing incidence of contrast media-associated nephropathy is being observed. This article reviews pathogenesis, clinical symptoms and preventive measures of contrast media-associated nephropathy. Most important prophylactic measures is identification of high-risk patients, careful selection to be exposed to contrast media, application of non-ionic low osmolality or - most recently - iso-osmolality contrast media, adjusted hydration with isotonic saline before/during catheter interventions, and potentially the administration of acetylcysteine.
Literatur
1
Agmon Y, Peleg H, Greenfield Z.
Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat.
J Clin Invest.
1994;
94
1069-1073
2
Andrale L, Campos S B, Seguro A C.
Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of L-arginine.
Kidney Int.
1998;
15
43-49
3
Aspelin P, Aubry P, Fransson S -G, Strasser R, Willenbrock R, Berg K J.
Nephrotoxic effetcs in high-risk patients undergoing angiography.
N Engl J Med.
2003;
348
491-499
4
Bach R, Jung F.
Optimales Röntgenkontrastmittel für die ambulante Koronarangio-graphie aus mikrozirkulatorischer Sicht.
Herz.
1998;
23
35-41
5
Bakris G L, Lass N A, Glock D.
Renal hemodynamics and radiocontrast medium-induced renal dysfunction: A role for dopamin-1 receptors.
Kidney Int.
1999;
56
206-210
6
Baliga R, Ueda N, Walker P D, Shah S V.
Oxidant mechanisms in toxic acute renal failure.
Am J Kidney Dis.
1997;
29
465-477
7
Barrett B J.
Contrast nephrotoxicity.
J Am Soc Nephrol.
1994;
5
125
8
Barrett B J, Carlisle E J.
Nephrotoxocity of high- and low-osmolality contrast media: a meta-analysis.
Radiology.
1993;
188
171-178
9
Barrett B J, Parfrey P S, Vasosour H M, O’Dea F, Kent G, Stone E, Reddy R, McManamon P J.
Contrast nephropathy in patients with impaired renal function: high versus low osmolar media.
Kidney Int.
1992;
41
1274-1279
10
Berns A S.
Nephrotoxicity of contrast media.
Kidney Int.
1989;
36
730-740
11
Briguori C, Manganelli F, Scarpato P, Elia P P, Briviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B.
Acetylcysteine and contrast agent-associated nephrotoxicity.
J Am Coll Cardiol.
2002;
40
298-303
12
Cantley L G, Spokes K, Clark B, McMahon E G, Carter J, Epstein F H.
Role of endo-thelin and prostaglandins in radioconstrast-induced renal artery constriction.
Kidney Int.
1993;
44
1217-1223
13
Chamsuddin A A, Kowalik K J, Bjarnason H.
Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy.
Am J Roentgenol.
2002;
179
591-595
14
Chu V L, Cheng J W.
Fenoldopam in the prevention of contrast media-induced acute renal failure.
Ann Pharmacother.
2001;
35
1278-1282
15
Cigarroa R G, Lange R A, Williams R H, Hillis L D.
Dosing of contrast material to prevent contrast nephropathy in patients with renal disease.
Am J Med.
1989;
86
649-652
16
Conlon P J, Schwab S J.
Time to abandon nonionic contrast?.
J Am Soc Nephrol.
1994;
5
123-125
17
Diaz-Sandoval L J, Kosowsky B D, Losordo D W.
Acetylcysteine to prevent angiography related renal tissue injury (The APART trial).
Am J Cardiol.
2002;
89
356-360
18
Duan S B, Liu F Y, Luo J A, Wu H W, Liu R H, Peng Y H, Yang X L.
Nephrotoxicity of high- and low-osmolar contrast media. The protective role of amlodipine in a rat mo-del.
Acta Radiol.
2000;
41
503-507
19
Erley C M, Duda S H, Schlepckow S, Koehler C M, Huppert P E, Strohmaier W L, Bohle A, Risler T, Osswald H.
Adenosine antagonist theophylline prevents the re-duction of glomerular filtration rate after contrast media application.
Kidney Int.
1994;
45
1425-1431
20
Forbes J M, Hewitson T D, Becker G J, Jones C L.
Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function.
Kidney Int.
2001;
59
1333-1341
21
Harris K G, Smith T P, cragg A H, Lemke J H.
Nephrotoxicity from contrast material in renal insufficiency: Ionic versus nonionic agents.
Radiology.
1991;
179
849-533
22
Haylor J L, Morcos S K.
Endothelin antagonism and contrast nephropathy.
Kidney Int.
2000;
58
2239
23
Hentschel M, Gildein P, Brandis M, Zimmerhackl L B.
Endothelin (ET-1) is involved in the contrast media induced nephrotoxicity in children with congenital heart disease.
Clin Nephrol.
1995;
43
12-15
24
Hess B.
Nephrologie im Alltag.
Primary Care Medicine.
2003;
3
1051-1054
25
Heyman S N, Brezis M, Epstein F H, Spokes K, Silva P, Rosen S.
Early renal medul-lary hypoxic injury from radiocontrast and indomethacin.
Kidney Int.
1991;
40
632-642
26
Heyman S N, Brezis M, Greenfeld Z, Rosen S.
Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat.
Am J Kidney Dis.
1989;
14
377-385
27
Hunter D.
Fenoldopam: A dopamine type-1 receptor agonist in the prevention of re-nal injury associated with the administration of intravenous contrast.
J Vasc Interv Radiol.
2000;
11
396-398
28
Ide J M, Lancelot E, Pines E, Corot C.
Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view.
Invest Radiol.
2004;
39
155-170
29
Kay J, Chow W H, Chan T M, Lo A K, Kwok O H, Yip A, Fan K, Lee C H, Lam W F.
Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention.
JAMA.
2003;
289
553-608
30
Koch J A, Plum J, Grabesee B, Modder U.
Prostaglandin E1: a new agent for pre-vention to renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group.
Nephrol Dial Transplant.
2000;
15
43-49
31
Kolonko A, Wiecek A, Kokot F.
The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiographic contrast agents.
J Nephrol.
1998;
11
151-156
32
Kramer B K, Kammerl M, Schweda F, Schreiber M.
A primer in radiocontrast-induced nephropathy.
Nephrol Dial Trasnplnat.
1999;
14
2830-2835
33
Kshirsagar A V, Poole C, Mottl A, Shoham D, Franceschini N, Tudor G, Agrawal M, Denu-Ciocca C, Ohman E M, Finn W E.
N-acetylcysteine for the prevention of radiocontrats induced nephropathy: a meta-analysis of prospective controlled trials.
J Am Soc Nephrol.
2004;
15
761-769
34
Kurnik B R, Allgren R L, Genter F C, Solomon R J, Bates E R, Weisberg L S.
Pro-spective study of atrial natriuretic peptide for the prevention of radiocontrast- induced nephropathy.
Am J Kidney Dis.
1998;
31
674-680
35
Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstadt H, Schollmeyer P.
Effect of haemodialysis after contrast medium administration in patients with renal insufficiency.
Nephrol Dial Transplant.
1998;
13
358-362
36
Liss P, Nygren A, Erikson U, Ulfendahl H R.
Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla.
Kidney Int.
1998;
53
698-702
37
Liss P, Nygren A, Hansell P.
Hypoperfusion in the renal outer medulla after injec-tion of contrast media in rats.
Acta Radiol.
1999;
40
521-527
38
Liss P, Nygren A, Olsson U, Ulfendahl H R, Erikson U.
Effects of contrast media and mannitol on the renal medullary blood flow and red cell aggregations in the rat kidney.
Kidney Int.
1996;
49
1268-1275
39
Manske C L, Sprafka J M, Strong J H, Wang Y.
Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.
Am J Med.
1990;
89
615-620
40
Mehran R, Aymong E D, Nikolsky E. et al .
A simple risk score for prediction of contrast-induced nephorpathy after percutaneous coronary intervention: development and initial validation.
J Am Coll Cardiol.
2004;
44
1393-1399
41
Merten G J, Burgess W P, Gray L V, Hollemann J H, Roush T S, Kowalehuk G J, Bersin R M, Moore A V, Simonton C A, Rittase R A, Norton H J, Kennedy T P.
Prevention of contrast-induced nephropathy with sodium bicarbonat.
JAMA.
2004;
291
2328-2334
42
Moore R D, Steinberg E P, Rowe N R.
Nephrotoxicity of high-osmolality versus low-osmolality contrast media: Randomized clinical trial.
Radiology.
1992;
182
649-652
43
Morcos S K, Thomsen H S, Webb J A.
Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safty Commitee, European Society of Urogenital Radiology.
Eur Radiol.
1999;
9
1602-1613
44
Morcos S K, Thomsen H S.
Adverse reaction to iodinated contrast media.
Eur Radiol.
2001;
11
1267-1279
45
Müller C, Buerkle G, Buettner H J, Petersen J, Perruchoud A P, Erikson U, Marsch S, Roskamm H.
Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.
Arch Intern Med.
2002;
162
329-336
46
Neumayer H H, Junge W, Kufner A, Wenning A.
Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial.
Nephrol Dial Transplant.
1989;
4
1030-1036
47
Newaz M A, Oyekan A O.
Vascular responses to endothelin-I, angiotensin-II, and u46619 in glycerol induced acute renal failure.
J Cardiovasc Pharmacol.
2001;
38
569-577
48
O’Meare J J, Dehmer G J.
Care of patients and mangement of complications after percutaneous coronary artery interventions.
Ann Int Med.
1997;
127
458-471
49
Oldemeyer J B, Cichowski E K, Wurdeman R L, Packard K, Biddle W, Mooss A.
Prophylactic acetylcysteine is not effective in preventing contrast-induced nephro-pathy following coronary angiography [abstract].
J Am Coll Cardiol.
2003;
41
328A
50
Pannu N, Manns B, Lee H, Tonell M.
Systematic review of the impact of N-acetylcysteine on contrast nephropathy.
Kidney Int.
2004;
65
1366-1374
51
Pflueger A, Larson T S, Nath K A, King B F, Gross J M, Knox F G.
Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus.
Mayo Clin Proc.
2000;
75
1275-1283
52
Rudnick M R, Berns J S, Cohen R M, Goldfarb S.
Nephrotoxic risks of renal angiography: Contrast-media associated nephrotoxicity and atheroembolism. A critical review.
Am J Kidney Dis.
1994;
24
713-716
53
Rudnick M R, Goldfarb S, Wexler L, Ludbrook P A, Murphy M J, Halpern E F, Hill J A, Winniford M, Cohen M B, van Fosen D B.
Nephrotoxicity of ionic and nonionic con-trast media in 1196 patients: a randomized trial.
Kidney Int.
1995;
47
254-261
54
Safirstein R.
Endothelin: the yin and yang of ischemic acute renal failure.
Kidney Int.
2001;
59
1590-1591
55
Schwab S J, Hlatky M A, Pieper K S, Davidson C J, Morris K G, Skelton T N, Bashore T M.
Contrast nephrotoxicity: a randomized control trial of a nonionic and an ionic radiographic contrast agent.
N Engl J Med.
1989;
320
149-153
56
Shyu K G, Cheng J J, Kuan P.
Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedures.
J Am Coll Cardiol.
2002;
40
1383-1387
57
Solomon R, Werner C, Mann D, D’Elia J, Silva P.
Effects of saline, mannitol, and furosemide to prevent acute decrease in renal function induced by radiocontrast agents.
N Engl J Med.
1994;
331
1416-1420
58
Taylor A J, Hotschkiss D, Morse R W, McCabe J.
PREPARED: Preparation for angio-graphy in renal dysfunction: a randomized trial of inpatients vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction.
Chest.
1998;
114
1570-1574
59
Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W.
Prevention of radiographic-contrast agent-induced reductions in renal function by acetyl-cysteine.
N Engl J Med.
2000;
343
180-184
60
Trivedi H S, Moore H, Nasr S, Aggarwal K.
A randomized prospective trial to assess the role of saline hydration on the deveolpemt of contrast nephrotoxicity.
Nephron.
2003;
93
C29
61
Tumlin J, Mathur V.
Prophylactic efficacy of feoldapam in radiocontrast nephropathy: A randomized, doubleblind, placebo-controlled trial.
J Vasc Interv Radiol.
2000;
11
175-178
62
Visweswaran P, Massin E K, DuBose T D.
Mannitol-induced acute renal failure.
J Am Soc Nephrol.
1997;
8
1028-1033
63
Vogt B, Ferrari P, Schönholzer C, Marti H P, Mohaupt M, Wiederkehr M, Cereghetti C, Serra A, Huynh Do U, Uehlinger D, Frey F J.
Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.
Am J Med.
2001;
111
692-698
64
Wang A, Holcslaw T, Bashore T M, Freed M I, Miller D, Rudnick M R, Szerlip H, Thames M D, Davidson C J, Shustermann N, Schwab S J.
Exacerbation of radio-contrast nephrootoxicity by endothelin receptor antagonism.
Kidney Int.
2000;
59
1590-1591
65
Weinrauch L A, Healy R W, Leland O S.
Coronary angiography and acute renal failure in diabetic azotemic nephropathy.
Ann Intern Med.
1977;
86
56-59
66
Weinstein J M, Heymann S, Brezis M.
Potential deleterious effect of furosemide in radiocontrast nephropathy.
Nephron.
1992;
62
413-415
67
Weisberg L S, Kurnik P B, Kurnik B R.
Radiocontrast-induced nephropathy in humans. Role of renla vasoconstriction.
Kidney Int.
1992;
41
1408-1413
68
Yao K, Heyne N, Erley C M, Risler T, Osswald H.
The selective adenosine A1 receptor antagonist KW-3902 presents radiocontrast media-induced nephropathy in rats with chronic nitric oxide defeiciency.
Eur J Pharmacol.
2001;
414
99-104
69
Yoshioka T, Fogo A, Beckman J K.
Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volumen depletion.
Kidney Int.
1992;
41
1008-1011
Prof. Christoph A. Nienaber
Universität Rostock, Klinik und Poliklinik für Innere Medizin, Abteilung Kardiologie
Ernst-Heydemannstraße 6
18057 Rostock
Phone: +49/0381/4947342
Fax: +49/0381/4947702
Email: christoph.nienaber@med.uni-rostock.de